Questcor Pharmaceuticals Inc (QCOR.O)

QCOR.O on Nasdaq

37.34USD
17 May 2013
Price Change (% chg)

$0.48 (+1.30%)
Prev Close
$36.86
Open
$37.07
Day's High
$37.97
Day's Low
$36.76
Volume
1,084,664
Avg. Vol
2,029,462
52-wk High
$58.91
52-wk Low
$17.25

QCOR.O

Chart for QCOR.O

About

Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the... (more)

Overall

Beta: 0.76
Market Cap (Mil.): $2,195.17
Shares Outstanding (Mil.): 59.55
Dividend: 0.25
Yield (%): 2.71

Financials

  QCOR.O Industry Sector
P/E (TTM): 11.41 34.17 34.44
EPS (TTM): 3.23 -- --
ROI: 81.61 19.17 18.54
ROE: 92.23 19.90 19.38
Search Stocks

Latest News about QCOR.O

Questcor profit misses estimates on weak Acthar sales

- Questcor Pharmaceuticals Inc's first-quarter profit lagged analysts' expectations as sales of its Acthar drug fell due to Medicaid reimbursement changes but the company said sales have bounced back in the current quarter.

30 Apr 2013

Questcor 1st-qtr adjusted profit missed estimates

April 30 - Questcor Pharmaceuticals Inc's first-quarter profit missed Street expectations as the number of prescriptions fell for its top-selling drug, Acthar, sending its shares down about 11 percent in after market trade.

30 Apr 2013
» More QCOR.O News

Competitors

  Price Change
GlaxoSmithKline plc (GSK.L) 1,712.50p +5.00
Novartis AG (NOVN.VX) CHF71.75 -0.45
Sanofi SA (SASY.PA) €84.50 -0.12
Pfizer Inc. (PFE.N) $28.96 -0.29
Johnson & Johnson (JNJ.N) $88.09 +0.64
Roche Holding Ltd. (ROG.VX) CHF247.00 +1.00
Merck & Co., Inc. (MRK.N) $45.99 -0.38
Abbott Laboratories (ABT.N) $36.59 -0.24
Bayer AG (BAYGn.DE) €83.79 -1.01
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - QUESTCOR PHARMACEUTICALS, INC. (QCOR-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of QUESTCOR PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
$20.00
Buy
ValuEngine Detailed Valuation Report for QCOR
Provider: ValuEngine, Inc.
$127.00
Buy
Market Edge Equity Research Report
Provider: Market Edge
$10.00
Buy
Questcor Pharmaceuticals
Provider: S&P Capital IQ Factual Report
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks